Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.27 USD | -7.78% | -15.61% | 0.00% |
Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 05 | Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 219M | |
+4.09% | 43.84B | |
+46.17% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- TSVT Stock
- News 2seventy bio, Inc.
- Wedbush Lowers Price Target fo 2seventy bio to $27 From $34, Maintains Outperform Rating